Voriconazole: a new triazole antifungal agent
Abstract
Voriconazole is a second-generation azole antifungal agent that shows excellent in vitro activity against a wide variety of yeasts and molds. It can be given by either the intravenous or the oral route; the oral formulation has excellent bioavailability. The side effect profile of voriconazole is un …
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
humans
pubmed abstract
nih
national institutes of health
national library of medicine
microbial sensitivity tests
liver / drug effects
antifungal agents / therapeutic use
pmid:12594645
doi:10.1086/367933
leonard b johnson
carol a kauffman
antifungal agents / adverse effects
antifungal agents / pharmacology*
aspergillosis / drug therapy
aspergillus / drug effects
candida / drug effects*
dermatitis / etiology
drug interactions
exanthema / etiology
pyrimidines / adverse effects
pyrimidines / pharmacology*
pyrimidines / therapeutic use
triazoles / adverse effects
triazoles / pharmacology*
triazoles / therapeutic use
voriconazole
Access
Citation
ID:
113557
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
113557
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet